Living with irritable bowel syndrome often means enduring a frustrating cycle: try a treatment, wait weeks for results, feel disappointed, and start all over again. Between 10% and 15% of U.S. adults are affected by the condition, and for many of them, finding relief feels less like medicine and more like guesswork. But a new clinical trial suggests that the bacteria living in your gut may already know which treatment has the best chance of working for you.
Why treatment prediction matters for IBS
Two of the most widely used treatments for IBS with diarrhea, known as IBS-D, are the low FODMAP diet and rifaximin, a prescription antibiotic. Both are backed by solid clinical evidence, yet each one works in fewer than half of all patients. That gap means the majority of people living with IBS-D spend months sometimes years moving through treatment options before they find any meaningful relief.
To explore whether gut bacteria could help close that gap, researchers enrolled 65 adults diagnosed with IBS-D and assigned them to one of two groups. One group received low FODMAP diet counseling, a structured eating plan that limits certain fermentable carbohydrates known to trigger digestive symptoms. The other group completed a five week course of rifaximin. Stool samples were collected throughout the trial to track each participant’s gut bacteria, and breath tests were also performed though those ultimately proved to be unreliable predictors of treatment response.
3 distinct bacterial profiles, 3 different outcomes
Both treatments produced real improvements. Participants in each group reported meaningful reductions in abdominal pain, bloating, and overall symptom severity. But when researchers analyzed the stool samples collected before treatment began, a clearer picture emerged: the types of bacteria already present in a person’s gut appeared to forecast which therapy would benefit them most.
People who responded well to the low FODMAP diet tended to have lower starting levels of bacteria responsible for breaking down sugars specifically Butyricimonas, Bacteroides and Intestinibacter. Those who responded to rifaximin had higher amounts of bacteria that produce beneficial compounds and assist with processing bile acids, including Ruminococcus, Coprococcus and Odoribacter. A third group those who did not respond to either treatment, had elevated levels of protein fermenting bacteria such as Bilophila, Alistipes and Prevotella a pattern the researchers associated with treatment resistance.
IBS may not be a single condition
The finding that three distinct bacterial profiles led to three different outcomes raises a broader and important question: is IBS actually one disease, or is it several different biological conditions that happen to produce similar symptoms?
Earlier research supports the idea that IBS is more complex than its single name implies. One previous study found that patients with a specific gut bacterial makeup improved significantly more on a low FODMAP diet compared to those with a different profile. Another study found that IBS-D patients whose gut bacteria showed signs of imbalance responded better to rifaximin than those whose microbiome more closely resembled that of healthy individuals.
Together, these findings suggest that a one size fits all treatment model may never fully serve this patient population. The gut-brain connection, the bidirectional communication pathway between digestive bacteria and the central nervous system may also help explain why these microbial differences have such a significant effect on treatment outcomes.
What people with IBS can do now
Routine gut bacteria testing to guide IBS treatment is not yet standard clinical practice, and the study authors acknowledge that their findings require further research before they can be applied broadly. Still, the research offers a useful framework.
Working with a gastroenterologist or registered dietitian remains one of the most practical steps a person can take. The low FODMAP diet in particular involves careful elimination and reintroduction phases that are significantly easier to navigate with professional support. In the meantime, prioritizing daily habits that promote a healthy gut including a fiber rich and varied diet can help lay the groundwork for better digestive health, whatever treatment path ultimately comes next.
